Preclinical evaluation of a novel polyphosphazene surface modified stent.
暂无分享,去创建一个
R. Virmani | A. Finn | F. Kolodgie | M. Joner | Eduardo Acampado | Qi Cheng | L. Maillard | K. Sakakura | Xiaoqin Zhao | Erica Pacheco | M. Barakat | T. Koppara | Jane Ren | M. Deshpande | Xiaoqing Zhao
[1] S. Buccheri,et al. Meta-Analyses of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation: Do Bleeding and Stent Thrombosis Weigh Similar on Mortality? , 2015, Journal of the American College of Cardiology.
[2] R. Virmani,et al. Acute Thrombogenicity of a Durable Polymer Everolimus-Eluting Stent Relative to Contemporary Drug-Eluting Stents With Biodegradable Polymer Coatings Assessed Ex Vivo in a Swine Shunt Model. , 2015, JACC. Cardiovascular interventions.
[3] R. Virmani,et al. Thrombogenicity and Early Vascular Healing Response in Metallic Biodegradable Polymer-Based and Fully Bioabsorbable Drug-Eluting Stents , 2015, Circulation. Cardiovascular interventions.
[4] Samin K. Sharma,et al. Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials. , 2015, Journal of the American College of Cardiology.
[5] Helmut Baumgartner,et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[6] C. Varenhorst,et al. Stent thrombosis in new-generation drug-eluting stents in patients with STEMI undergoing primary PCI: a report from SCAAR. , 2014, Journal of the American College of Cardiology.
[7] R. Virmani,et al. Pathology of Second-Generation Everolimus-Eluting Stents Versus First-Generation Sirolimus- and Paclitaxel-Eluting Stents in Humans , 2014, Circulation.
[8] P. Serruys,et al. The EXAMINATION trial (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction): 2-year results from a multicenter randomized controlled trial. , 2014, JACC. Cardiovascular interventions.
[9] M. Mack,et al. Short-term and long-term clinical impact of stent thrombosis and graft occlusion in the SYNTAX trial at 5 years: Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery trial. , 2013, Journal of the American College of Cardiology.
[10] R. Virmani,et al. Preclinical evaluation of second-generation everolimus- and zotarolimus-eluting coronary stents. , 2013, The Journal of invasive cardiology.
[11] R. Virmani,et al. Intracoronary optical coherence tomography and histology of overlapping everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: the potential implications for clinical practice. , 2013, JACC. Cardiovascular interventions.
[12] P. Serruys,et al. Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial , 2012, The Lancet.
[13] Laura Mauri,et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. , 2011, Circulation.
[14] G. Richardt,et al. Long-term clinical outcome of thin-strut cobalt-chromium stents in the drug-eluting stent era: results of the COBALT (comparison of bare-metal stents in all-comers' lesion treatment) registry. , 2011, Journal of interventional cardiology.
[15] R. Latini,et al. Multi-Link Vision stent vs. first-generation drug-eluting stents: systematic review and meta-analysis. , 2011, QJM : monthly journal of the Association of Physicians.
[16] D. Capodanno,et al. The Rapid Evaluation of Vessel Healing after Angioplasty (REVEAL) trial , 2011 .
[17] R. Virmani,et al. Endothelial cell recovery, acute thrombogenicity, and monocyte adhesion and activation on fluorinated copolymer and phosphorylcholine polymer stent coatings. , 2010, Biomaterials.
[18] R. Virmani,et al. Comparison of Inflammatory Response After Implantation of Sirolimus- and Paclitaxel-Eluting Stents in Porcine Coronary Arteries , 2009, Circulation.
[19] C. Bode,et al. Differences of platelet adhesion and thrombus activation on amorphous silicon carbide, magnesium alloy, stainless steel, and cobalt chromium stent surfaces , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[20] Ulrike Stampfl,et al. Reduction of Late In-Stent Stenosis in a Porcine Coronary Artery Model by Cobalt Chromium Stents with a Nanocoat of Polyphosphazene (Polyzene-F) , 2008, CardioVascular and Interventional Radiology.
[21] I. Berger,et al. Efficacy of a polyphosphazene nanocoat in reducing thrombogenicity, in-stent stenosis, and inflammatory response in porcine renal and iliac artery stents. , 2008, Journal of vascular and interventional radiology : JVIR.
[22] Ju Han Kim,et al. Inflammation and delayed endothelization with overlapping drug-eluting stents in a porcine model of in-stent restenosis. , 2008, Circulation journal : official journal of the Japanese Circulation Society.
[23] Ulrike Stampfl,et al. Restenosis of the CYPHER-Select, TAXUS-Express, and Polyzene-F Nanocoated Cobalt-Chromium Stents in the Minipig Coronary Artery Model , 2008, CardioVascular and Interventional Radiology.
[24] P. Libby,et al. Mast cells promote atherosclerosis by releasing proinflammatory cytokines , 2007, Nature Medicine.
[25] M. Grunze,et al. The Efficacy of Nanoscale Poly[bis(trifluoroethoxy) phosphazene] (PTFEP) Coatings in Reducing Thrombogenicity and Late In-Stent Stenosis in a Porcine Coronary Artery Model , 2007, Investigative radiology.
[26] Michael Joner,et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. , 2006, Journal of the American College of Cardiology.
[27] Yong Woo Lee,et al. Role of interleukin-4 in atherosclerosis , 2006, Archives of pharmacal research.
[28] C. Mackay,et al. Gene Profiling in Atherosclerosis Reveals a Key Role for Small Inducible Cytokines: Validation Using a Novel Monocyte Chemoattractant Protein Monoclonal Antibody , 2005, Circulation.
[29] M. Grunze,et al. A New Polymer Concept for Coating of Vascular Stents Using PTFEP (poly(bis(trifluoroethoxy)phosphazene) to Reduce Thrombogenicity and Late In-Stent Stenosis , 2005, Investigative radiology.
[30] R. Franke,et al. Haemocompatibility of polymer-coated stainless steel stents as compared to uncoated stents. , 2005, Clinical hemorheology and microcirculation.
[31] R. Virmani,et al. Preclinical restenosis models and drug-eluting stents: still important, still much to learn. , 2004, Journal of the American College of Cardiology.
[32] F. Cambien,et al. Impact of pathogen burden in patients with coronary artery disease in relation to systemic inflammation and variation in genes encoding cytokines. , 2003, The American journal of cardiology.
[33] M. Eisenberg,et al. Coated stents for the prevention of restenosis: Part I. , 2002, Circulation.
[34] M. Tabrizian,et al. Nitinol versus stainless steel stents: acute thrombogenicity study in an ex vivo porcine model. , 2002, Biomaterials.
[35] Renu Virmani,et al. Morphological Predictors of Restenosis After Coronary Stenting in Humans , 2002, Circulation.
[36] B. Bouchard,et al. Platelets, leukocytes, and coagulation , 2001, Current opinion in hematology.
[37] M. Bureau,et al. Protective role of interleukin-10 in atherosclerosis. , 1999, Circulation research.
[38] A. Tedgui,et al. Expression of interleukin-10 in advanced human atherosclerotic plaques: relation to inducible nitric oxide synthase expression and cell death. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[39] R. Ross,et al. Atherosclerosis is an inflammatory disease. , 1998, American heart journal.
[40] Welle,et al. Plasma Protein Adsorption and Platelet Adhesion on Poly , 1998, Journal of colloid and interface science.
[41] L. Demer,et al. Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. , 1996, The Journal of clinical investigation.
[42] E. Edelman,et al. Endovascular stent design dictates experimental restenosis and thrombosis. , 1995, Circulation.
[43] R E Vlietstra,et al. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. , 1992, Journal of the American College of Cardiology.